Information:
Fel:
ID
33156
Beskrivning
Effects of Different Types of Exercise in Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01182948
Länk
https://clinicaltrials.gov/show/NCT01182948
Nyckelord
Versioner (1)
- 2018-11-29 2018-11-29 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
29 november 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Type 2 Diabetes NCT01182948
Eligibility Type 2 Diabetes NCT01182948
- StudyEvent: Eligibility
Similar models
Eligibility Type 2 Diabetes NCT01182948
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Body mass index
Item
bmi between 24-36 kg/m2;
boolean
C1305855 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
hba1c between 6.5-9.0%;
boolean
C0474680 (UMLS CUI [1])
Diabetes Mellitus Disease length
Item
diabetes diagnosis must have been made at least 1 yr previously;
boolean
C0011849 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
C0872146 (UMLS CUI [1,2])
Diabetes Therapy | Diet therapy | Oral hypoglycemic
Item
admitted diabetes treatments will be diet and oral hypoglycemic agents;
boolean
C3274787 (UMLS CUI [1])
C0012159 (UMLS CUI [2])
C0359086 (UMLS CUI [3])
C0012159 (UMLS CUI [2])
C0359086 (UMLS CUI [3])
Physical activity International Physical Activity Questionnaire (IPAQ)
Item
baseline physical activity, estimated by the ipaq questionnaire, lower than 1000 met min per week;
boolean
C0026606 (UMLS CUI [1,1])
C4319956 (UMLS CUI [1,2])
C4319956 (UMLS CUI [1,2])
Stable body weight
Item
baseline body weight stable (changes lower than 2 kg in the last 2 months).
boolean
C0517386 (UMLS CUI [1])
Neuropathy Somatic Moderate | Neuropathy Somatic Severe | Autonomic neuropathy Moderate | Autonomic neuropathy Severe
Item
moderate-severe somatic or autonomic neuropathy;
boolean
C0442874 (UMLS CUI [1,1])
C2986476 (UMLS CUI [1,2])
C0205081 (UMLS CUI [1,3])
C0442874 (UMLS CUI [2,1])
C2986476 (UMLS CUI [2,2])
C0205082 (UMLS CUI [2,3])
C0259749 (UMLS CUI [3,1])
C0205081 (UMLS CUI [3,2])
C0259749 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
C2986476 (UMLS CUI [1,2])
C0205081 (UMLS CUI [1,3])
C0442874 (UMLS CUI [2,1])
C2986476 (UMLS CUI [2,2])
C0205082 (UMLS CUI [2,3])
C0259749 (UMLS CUI [3,1])
C0205081 (UMLS CUI [3,2])
C0259749 (UMLS CUI [4,1])
C0205082 (UMLS CUI [4,2])
Coronary heart disease
Item
coronary heart disease;
boolean
C0010068 (UMLS CUI [1])
Peripheral Vascular Disease | Cerebrovascular Disorder
Item
peripheral or cerebral vascular disease;
boolean
C0085096 (UMLS CUI [1])
C0007820 (UMLS CUI [2])
C0007820 (UMLS CUI [2])
Preproliferative diabetic retinopathy | Proliferative retinopathy | Kidney Failure, Chronic | Creatinine measurement, serum | Gender
Item
preproliferative or proliferative retinopathy or chronic renal failure (serum creatinine >1.4 mg/dl in females; >1.5 mg/dl in males);
boolean
C0339473 (UMLS CUI [1])
C0339467 (UMLS CUI [2])
C0022661 (UMLS CUI [3])
C0201976 (UMLS CUI [4])
C0079399 (UMLS CUI [5])
C0339467 (UMLS CUI [2])
C0022661 (UMLS CUI [3])
C0201976 (UMLS CUI [4])
C0079399 (UMLS CUI [5])
Adrenergic beta-1 Receptor Antagonists
Item
therapy with beta-blocker drugs;
boolean
C0304516 (UMLS CUI [1])
Tobacco use
Item
smokers;
boolean
C0543414 (UMLS CUI [1])
Comorbidity Clinical Significance
Item
acute clinically significant intercurrent diseases;
boolean
C0009488 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,2])
Physical activity Scheduled Unable
Item
inability to perform the scheduled physical activity programs.
boolean
C0026606 (UMLS CUI [1,1])
C0205539 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
C0205539 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])